SuperworthRevelation Biosciences market cap REVB
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $2.2M
- Highest close in our data
- $62.8M
- Jan 2022
Revelation Biosciences is worth $2.2M at the close on Oct 23, 2026, at $3.79 a share.
That is down 0% over the last year and down 92% over five years.
Its highest close in our data was $62.8M in Jan 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2M | $1.9M | $5.6M | −58% |
| 2025 | $5.1M | $719.6K | $6.2M | +231% |
| 2024 | $1.5M | $497.5K | $4.5M | −51% |
| 2023 | $3.2M | $948.2K | $6.7M | −30% |
| 2022 | $4.5M | $4.2M | $62.8M | −86% |
| 2021 | $30.9M | $26.5M | $32.2M | −1% |
| 2020 | $31.1M | $30.3M | $31.2M | n/a |
Against its peers
Companies in Healthcare nearest Revelation Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| REVBRevelation Biosciences | $2.2M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| BCGBinah Capital | $18.2M |
| VIPVulcan Infrastructure & Power | $19.6M |
| MXCMexco Energy | $20.5M |
| CKXCKX Lands | $21.5M |
| Peer median | $16.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Revelation Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.